Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2026-03-26 @ 3:15 PM
Ignite Modification Date:
2026-03-26 @ 3:15 PM
NCT ID:
NCT07336992
Eligibility Criteria:
Inclusion Criteria:
* Age ≥ 18 years
* Spontaneous (non-traumatic) supratentorial intracerebral haemorrhage diagnosed by brain CT or MRI
* Onset of neurologic symptoms within 24 hours
* NIHSS score on admission ≤ 25
* Informed consent given by the patient or his/her legal representative
* Patients benefiting from a social insurance system or a similar system
Exclusion Criteria:
* Intracerebral haemorrhage known or suspected by study investigator to be secondary to trauma, vascular malformation, haemorrhagic transformation of ischaemic stroke, or tumour
* Current use of antiseizure drugs or history of epilepsy
* Severe renal insufficiency (creatinine clearance \< 30 ml/min)
* Pregnancy or breastfeeding
* Previous history of severe depression or psychotic disorder
* Known terminal illness
* Known allergy or hypersensitivity to levetiracetam
* Known allergy or hypersensitivity to microcrystalline cellulose or lactose
* Being under legal protection
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT07336992
Study Brief:
Protocol Section:
NCT07336992